Cantor Fitzgerald reaffirmed its Overweight rating on Neurocrine Biosciences stock (NASDAQ:NBIX) with a consistent price target of $170.00. Currently trading at $150.51, the stock has shown strong ...

Cantor Fitzgerald analyst Deepak Mathivanan maintained a Buy rating on Pinterest (PINS – Research Report) today and set a price target of ...

It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...

In a report released today, Deepak Mathivanan from Cantor Fitzgerald maintained a Hold rating on Expedia (EXPE – Research Report), with a price ...

Cantor Fitzgerald adjusted its price target for Fortinet shares (NASDAQ:FTNT) to $115.00, an increase from the previous target of $110.00. The firm maintained a Neutral stance on the cybersecurity ...

A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...

Howard Lutnick, a billionaire banker poised to run the Department of Commerce, has deep ties to the crypto industry. But he ...

Analysts at Cantor Fitzgerald lowered their FY2025 EPS estimates for shares of PTC Therapeutics in a report released on ...

Lutnick is CEO of Cantor Fitzgerald, previous owner of Cantor Gaming. The company reportedly violated state and federal ...

Cantor Fitzgerald boosted their FY2025 earnings per share estimates for shares of Palantir Technologies in a report released on Tuesday, February 4th. Cantor Fitzgerald analyst T. Blakey now ...

Howard Lutnick, President Donald Trump's nominee for Commerce Secretary and CEO of Cantor Fitzgerald, says the firm has no ...